Collaboration Lead Compound definition

Collaboration Lead Compound means any Collaboration Compound selected by Warner for further development as provided in Section 5.1.
Sample 1Sample 2Sample 3
Collaboration Lead Compound shall have the meaning set forth in Section 4.02(b).
Sample 1
Collaboration Lead Compound means an Allergan Designated Compound selected by Allergan pursuant to Section 4.5 hereof as lead drug development compounds for further pre-clinical and clinical development and commercialization for use in the Field.
Sample 1

Examples of Collaboration Lead Compound in a sentence

  • The Parties, under the direction of the RMC shall conduct Pre-Clinical Development with respect to any designated Collaboration Lead Compound.

  • On a Collaboration Lead Compound-by-Collaboration Lead Compound basis, either Party may elect (upon [ * ] written notice following receipt by the Party contemplating termination of its participation in the Pre-Clinical Development of any Collaboration Lead Compound or Development of any Product of Development Termination Documents) to terminate its participation in, or to not to participate in, the Pre-Clinical Development of any Collaboration Lead Compound or Development of any Product.

  • In addition, the RMC will be responsible for coordinating all aspects of all activities (including, but not limited to: [ * ] that will be undertaken with respect to a Collaboration Lead Compound that are necessary or desirable to enable the filing of an IND on Products based upon or incorporating such Collaboration Lead Compound, including the preparation and filing of an IND (collectively, "Pre-Clinical Development").

  • Promptly following the designation of a Collaboration Lead Compound pursuant to Section 3(b), the JDC shall initiate preparation of the development plan for the Development (the "Development Plan") and a budget (the "Development Budget") for proposed Development Costs (as defined in Section 3(f)).

  • The RMC will be responsible for coordinating all aspects of all activities undertaken to identify and develop a Lead Compound that are necessary or desirable to determine whether such Lead Compound may be suitable for designation as a Collaboration Lead Compound pursuant to Section 3(b)(i).

  • Under no circumstances shall either Party conduct studies of any Collaboration Lead Compound in the Field except as permitted by the RMC.

  • From time to time, Onyx may request Warner in writing to undertake specific research and development regarding a Collaboration Compound or to declare a Collaboration Compound to be a Collaboration Lead Compound.

  • Such licenses with respect to a Collaboration Lead Compound are co-exclusive between Onyx and Warner.

  • In such event, such Onyx Lead Compound shall immediately become a Collaboration Lead Compound for all purposes under this Agreement.

  • Warner will provide Onyx quarterly, written updates regarding the status of each Collaboration Lead Compound.


More Definitions of Collaboration Lead Compound

Collaboration Lead Compound means a Collaboration Compound or Background Technology compound that, during the term of the Research Program or any extension thereof, has met criteria established by the JRC of safety and efficacy for advancement into Pre-Clinical Development and which is selected by Xxxxxx-Xxxxxxx as a Collaboration Lead Compound according to Section 4.1.
Sample 1
Collaboration Lead Compound means a Collaboration Compound or Background Technology compound, other than Ligand Background Technology compounds that are "Existing Compounds," and whose commercial use is restricted, *** that has met criteria established by the JRC of safety and efficacy for advancement into Pre-Clinical Development during the Research Term or any extension thereof and which is selected by Organon as a Collaboration Lead Compound according to Section 4.1. Attached hereto as Exhibit D is a complete list of the Ligand Background Technology compounds whose commercial use is restricted ***.
Sample 1
Collaboration Lead Compound means [***]Compound selected by Allergan pursuant to Section 4.5 hereof as [***] and commercialization for use in the Field.
Sample 1
Collaboration Lead Compound means a Lead Compound Discovered as part of the Collaboration.
Sample 1
Collaboration Lead Compound means a Collaboration Compound or Background Technology compound, other than Ligand Background Technology compounds that are "Existing Compounds," and whose commercial use is restricted,
Sample 1
Collaboration Lead Compound means a Collaboration Compound that is selected by BMS for Pre-Clinical Development. Except where the context clearly indicates otherwise, references to Collaboration Compounds shall cover Collaboration Lead Compounds as well.
Sample 1

Related to Collaboration Lead Compound

  • Collaboration Compound means any of the following: (a) FG-4592, (b) any HIF Compound (other than FG-4592) that is added to this Agreement pursuant to Section 3.6, and (c) any salts, esters, complexes, chelates, crystalline and amorphous morphic forms, pegylated forms, enantiomers (excluding regioisomers), prodrugs, solvates, metabolites and catabolites of any of the foregoing ((a) or (b)).

  • Lead Compound means any compound of lead other than galena which, when treated in the manner described below, yields to an aqueous solution of hydrochloric acid a quantity soluble lead compound exceeding, when calculated as lead monoxide, five percent of the dry weight of the portion taken analysis.

  • Collaboration Target means the Initial Collaboration Targets set forth on Exhibit F and any Additional Target or Substitute Target that is selected in accordance with Section 3.3 of this Agreement.

  • Collaboration Product means a pharmaceutical product containing or comprising Compound in any dosage form alone, or in combination with, one or more other pharmaceutically active ingredients, and any and all Improvements thereto.

  • Development Candidate means a Compound that meets the Development Candidate Criteria for the initiation of a Development Program for the treatment of CF, and which is the subject of a notice from Vertex to CFFT that Vertex intends to commence formal pre-clinical development of the Compound in the Field pursuant to the provisions of Section 3.1 hereof.

  • Licensed Compound means (a) 3,4-Diaminopyridine, the chemical structure of which is set forth on Exhibit B-2; and (b) any derivatives, isomers, metabolites, prodrugs, acid forms, base forms, salt forms, or modified versions of such compound in (a).

  • Licensed Compounds means any EZH2 Compound(s) that is:

  • Product Candidate means each of MYO-101, MYO-102, MYO-103, MYO-201 and MYO-301, as defined on Exhibit B, in each case in any form or formulation.

  • Research Plan shall have the meaning set forth in Section 2.1.

  • Research Program has the meaning set forth in Section 2.1.

  • Research Program Term has the meaning set forth in Section 2.2.

  • Collaboration has the meaning set forth in Section 2.1.

  • Collaboration Term has the meaning set forth in Section 2.2.

  • Commercialization Plan has the meaning set forth in Section 6.2.

  • Collaboration Know-How means all Know-How conceived, discovered, developed or otherwise made by or on behalf of a particular Party or any of its Affiliates or permitted subcontractors of any of the foregoing (solely or jointly by or on behalf of a particular Party or any of its Affiliates or permitted subcontractors of any of the foregoing) in the course of [***].

  • Collaboration Patent Rights means Patent Rights claiming Collaboration Know-How.

  • Commercialization or “Commercialize” means activities directed to marketing, promoting, research and development as required, manufacturing for sale, offering for sale, distributing, importing or selling a product, including sub-licensing or sub-contracting of these activities.

  • Collaboration Patents means any and all Patents that claim or cover any of the Collaboration Know-How.

  • Collaboration IP means Collaboration Know-How and Collaboration Patents.

  • Development Program means the implementation of the development plan.

  • Development Plan has the meaning set forth in Section 3.2.

  • Collaborative matter means a dispute, transaction, claim, problem, or issue for resolution, including a dispute, claim, or issue in a proceeding, that is described in a collaborative law participation agreement and arises under the family or domestic relations law of this state, including any of the following:

  • Phase IIb Clinical Trial means a clinical trial of a Product on sufficient numbers of patients that is designed to provide a preliminary determination of safety and efficacy of such Product in the target patient population over a range of doses and dose regimens.

  • Joint Commercialization Committee or “JCC” has the meaning set forth in Section 2.1(a).

  • Development Activities means those activities which are normally undertaken for the development, construction, repair, renovation, rehabilitation or conversion of buildings for residential purposes, including the acquisition of property;

  • Phase I Clinical Study means, as to a particular Licensed Product, an initial clinical study in humans with the purpose of assessing the Licensed Product’s safety, tolerability, toxicity, pharmacokinetics or other pharmacological properties.